How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation?
Authors:
- 1 October 2014
- journal article
- Published by Elsevier in Human Pathology
- Vol. 45 (10) , 2029-2036
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut, 2013
- Performance of PREMM1,2,6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer casesGenetics in Medicine, 2012
- Reflex Immunohistochemistry and Microsatellite Instability Testing of Colorectal Tumors for Lynch Syndrome Among US Cancer Programs and Follow-Up of Abnormal ResultsJournal of Clinical Oncology, 2012
- Comparison of the clinical prediction model PREMM 1,2,6 and molecular testing for the systematic identification of Lynch syndrome in colorectal cancerGut, 2012
- Inherited Colorectal Cancer SyndromesThe Cancer Journal, 2011
- The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer HistoryGastroenterology, 2011
- Report From the Jerusalem Workshop on Lynch Syndrome-Hereditary Nonpolyposis Colorectal CancerGastroenterology, 2010
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Clinical Guidelines Versus Universal Molecular Testing: Are We Ready to Choose an Optimal Strategy for Lynch Syndrome Identification?American Journal of Gastroenterology, 2008
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005